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Preface 
Student’s Role 
I completed this project in a voluntary capacity within the School of Public Health and 
Community Medicine (SPHCM) at the University of New South Wales (UNSW) Australia, 
between June and November of 2016. Although already employed full-time as a post-
doctoral fellow in the School of Psychiatry at UNSW, I sought to undertake a project that 
would allow me to develop skills beyond those utilised in my regular employment, and to 
apply these skills to an area of research with which I had no prior experience. After an initial 
discussion with my project supervisor Prof. Andrew Hayen and content supervisor Dr. Sally 
Nathan, I was afforded the opportunity to contribute to their ongoing program of research 
entitled “Positive life pathways for vulnerable adolescents: The role of a life management 
program approach”. This project is conducted in partnership with the Ted Noffs Foundation, 
which provides a residential treatment program for adolescents experiencing problematic use 
of drugs and alcohol (Program for Adolescent Life Management; PALM).   
 
My role in the project, as negotiated with the supervisory team, was to utilise routinely-
collected intake assessment and three month follow-up data to broadly explore the impact of 
amphetamine-type stimulant use (such as methamphetamine and crystal methamphetamine) 
on adolescent treatment outcomes. I was issued with a relatively large data file (with over 
1000 variables and 2985 observations), and was responsible for: determining and extracting 
suitable observations; cleaning the data; recoding or creating new variables to adequately 
capture the predictor and outcome variables of interest, including the calculation of 
composite scores / questionnaire subscales; determining the most appropriate predictor and 
outcome variables; selecting and performing the most appropriate statistical analyses; and 
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reporting of the outcomes of these analyses. Prof. Andrew Hayen assisted with the selection 
of appropriate analytic techniques and revision of the final document, and Dr. Sally Nathan 
provided suggestions as to the variables of most interest to explore in the analysis. The results 
of this project have been presented as a consulting report; and are currently in preparation for 
submission to a peer-reviewed journal.   
Reflections on Learning 
Communication 
It was refreshing to work with a different team of researchers on this project in an alternative 
capacity to what I am used to in my normal work role. This required me to further develop 
skills for communicating statistical concepts without using technical jargon, and to explain 
(and on occasion, justify) the choice of an analysis technique or the use of one particular 
variable over another in a clear and understandable way, both written and verbally. Weekly 
meetings were organised between myself and my biostatistical supervisor during which I 
provided updates on progress to date and discussed any issues with the data or analysis 
techniques when they arose. Approximately monthly meetings were held with both content 
and biostatistical supervisors. The frequency of these meetings was sufficient to allow me 
independence in the direction of the data analysis, yet facilitated constant feedback to 
efficiently and successfully achieve the project aims.  
Work Patterns and Planning 
I undertook this project in addition to my normal full-time job and a relatively demanding 
BCA coursework unit, and was not afforded time within my regular workday to complete 
project-related tasks. I attempted to balance and carefully plan the limited time I had 
available, with the aim of dedicating approximately 8 hours a week to the project. However, 
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the absence of firm deadlines or external pressure to finish made it challenging when other 
tasks arose (e.g., coursework assessments, grant applications, paper reviews and revisions) 
which had far less flexible timelines. This resulted in reduced engagement with the project 
than planned in some weeks. Overall, I feel that I managed to stay on track and make up for 
lost time by becoming familiar with the variables included in the dataset by generating 
descriptive statistics and cross-tabulations, carefully considering the analytic approach to be 
taken with these forms of data, and consulting with both my statistical and content 
supervisors in situations where clarification was required to avoid building and refining 
redundant or nonsensical statistical models.  
Statistical Principles and Methods 
I was fortunate in that the broad aims and research questions were already defined prior to my 
joining the project; however I was given free rein to decide which cases in the sample to 
include, the most appropriate outcome measures, and the analysis approach to take.  
Prior to engaging in this project, my applied statistical experience had predominantly been in 
experimental psychology (where small and quantifiable manipulations are made to a stimulus 
with all other factors held constant by design) and psychoneuroimmunology (utilising 
physiological time series data, such as continuous heart rate, and measures of performance on 
physical and cognitive tasks). Thus, most of the data I have worked with has been primary 
data which I collected myself, and typically in the form of continuous, objective variables 
that are well-defined and can be easily interpreted even when transformation is required to 
meet assumptions of an analysis. In contrast, the dataset I worked with for this project 
included multi-site administrative data for which the primary purpose of collection is not 
research, comprising almost exclusively subjective, self-report data. From just the initial 
exploration of the data, the typical problems associated with subjective and administrative 
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data become very clear, very quickly. There was an abundance of missing data on even 
simple dichotomous variables, or variables with out of range values. In some cases, it was a 
systematic data entry error which was fairly easy to amend or confidently infer based on 
previous variables (e.g., having an observation with a blank response, which should have 
been coded as a “no”); but at other times resulted in cases being unusable due to excessive 
missing data.  
I employed a number of data management and statistical methods that I had acquired a 
theoretical knowledge of over the past three years in the BCA program. Notably the project 
allowed me to develop a better understanding of methods pertaining to the analysis of ordinal 
categorical and count data, which I had not previously used in practice, and techniques for 
assessing model assumptions and goodness-of-fit.  
Statistical Computing 
Stata 13.1 was utilised for all analyses conducted in this report. Stata has been the software of 
choice across most of the BCA units that I have completed over the last three years of study, 
so I was already familiar with it for basic data management and analysis. The course notes 
from various units provided to be extremely useful reference source, along with the Stata help 
files to ensure that the commands being entered were generating the expected output. The 
UCLA Institute for Digital Research and Education (IDRE) extensive online collection of 
annotated output and analysis examples (http://www.stats.idre.ucla.edu/) were also consulted 
frequently. 
Team Work 
This project was undertaken as an independent workplace project, as part of a broader 
program of research conducted by my project supervisors. There was some overlap with other 
projects being conducted (i.e., by other students), so there was ongoing discussion throughout 
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the project ensuring everyone was on the same page, and that the same data cleaning 
processes and interpretations of variables were being consistently applied across projects. As 
my role on the project was negotiated prior to commencement, and a broad research question 
was proposed, I worked fairly independently throughout its completion. This resulted in a 
flexible timeline within which to work; however frequent communication was maintained 
with my supervisors, who were extremely supportive throughout the project, and provided 
assistance when needed. 
Ethical Considerations 
The broader research program entitled “Length of stay and PALM: A residential treatment 
program for young people with drug and/or alcohol dependence” has received ethical 
approval from the University of New South Wales Human Research Ethics Committee 
(Reference #: HC13014). I was added as an investigator on the project before gaining access 
to the data. The study has been conducted in accordance with the National Health and 
Medical Research Council’s (NHMRC) National Statement on Ethical Conduct in Human 
Research (2007). All data made available to me was administrative data collected by the 
PALM program team at intake and follow-up, and provided in a de-identified format in order 
to maintain the anonymity of the PALM clients. No personally identifiable information was 
provided with the dataset.  
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Project Report 
Project Summary 
Project Title The impact of amphetamine-type stimulant use on program achievement 
and post-treatment outcomes after a residential life management program 
for adolescent drug users 
Location and 
Dates 
School of Public Health and Community Medicine,  
University of New South Wales, June 2016 – November 2016 
Context This project was undertaken in a voluntary capacity as part of a broader 
program of research entitled “Positive life pathways for vulnerable 
adolescents: The role of a life management program approach”. This project 
explored the impact of amphetamine-type stimulant use on achievement in 
the program for over 2000 adolescents with problematic drug or alcohol 
usage, and longer-term outcomes for a subset of these individuals who were 
followed-up 3 months after discharge from the program.   
Student 
Contribution 
I was responsible for the selection and extraction of suitable observations; 
data cleaning and processing; selection of predictors and outcomes; 
performing statistical analyses; and reporting of the outcomes of these 
analyses. 
Statistical 
Issues 
Involved 
Multivariate regression analyses, including: 
- Ordinal logistic regression 
- Multivariate linear regression 
- Negative binomial regression 
Declaration I declare this project is evidence of my own work, with direction and 
assistance provided by my project supervisor. This work has not been 
previously submitted for academic credit.  
Signature 
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independent researcher.  I have had to provide minimal supervision to 
Erin, as he has been able to work on the data management, analyses, 
and write-up independently.  Our discussions about the work have 
mainly been for the purposes of clarification, or as a discussion 
between colleagues.    
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List of Abbreviations 
 
ACT Australian Capital Territory 
ATS Amphetamine-type stimulant 
BSI Brief symptom inventory 
BTOM Brief Treatment Outcome Measure 
CI Confidence interval 
DGC Drug of greatest concern 
NSW New South Wales 
PALM Program for Adolescent Life Management 
PSDI Positive Symptom Distress Index 
SD Standard deviation 
SE Standard error 
SFS Social Functioning Scale 
SDS Severity of Dependence Scale 
TNF Ted Noffs Foundation 
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Project Description 
Background 
Young people in contact with the criminal justice system often have complex health, social, 
and care needs. In addition to increased rates of socio-economic disadvantage, psychiatric 
disorders, and cognitive disability, these individuals report a greater use of drugs and alcohol 
compared to age-matched individuals within the general community [1-3]. Problematic use of 
drugs and alcohol, when combined with other disadvantageous circumstances, often enmesh 
these individuals in the criminal justice system; with these negative factors associated with 
continued offending and poor health outcomes into and throughout adulthood [4].  
 
A small number of community-based support programs are available which attempt to 
address multiple life problems for adolescents who are experiencing problematic use of drugs 
and alcohol, many of whom have had previous contact with the juvenile justice system. The 
Ted Noffs Foundation’s (TNF’s) Program for Adolescent Life Management (PALM) is one 
such program. PALM offers up to three months of residential treatment, followed by up to 12 
months of continued care. Based on a harm reduction philosophy and relapse prevention 
planning, PALM provides a holistic, intensive, multi-disciplinary program staffed by 
professionals specifically trained in working through trauma, challenging behaviours, and 
complex needs. The structured program offers counselling, family support, group work, 
vocational/educational modules, living skills and recreational activities. To be eligible for 
PALM, individuals must be aged between 13 and 18 years, experiencing problematic 
substance use, and not exhibiting significant violence, sexual acting out, or an acute 
uncontrolled psychiatric condition. Individuals that do not meet these criteria are referred to 
more suitable services, including general practitioners, local mental health teams, legal aid, or 
detoxification / rehabilitation facilities. 
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Population-level studies suggest that alcohol, tobacco, and cannabis are the most commonly 
used drugs amongst adolescents, whereas the use of methamphetamine has remained low and 
relatively stable amongst adolescents and in the overall population [5]. However, a recent 
report [6] of PALM clients, representing a large proportion of the adolescent treatment 
population in New South Wales (NSW) and Australian Capital Territory (ACT) who are 
unlikely to be captured by population-based surveys, has highlighted a substantial increase in 
the reported use of methamphetamine and the endorsement of methamphetamine as the drug 
of greatest concern (DGC) over the 5-year period from 2009 to 2014. The endorsement of 
methamphetamine as the DGC increased from 10.8% in 2009 to 48.4% in 2014, whilst use of 
methamphetamine prior to admission to PALM increased from 28.8% in 2009 to 59.4% in 
2014.  
 
Amphetamine-type stimulants (ATS) refer to the family of synthetic drugs that are 
chemically related to the parent compound amphetamine, and include methamphetamine and 
crystal methamphetamine [7]. These psychostimulant compounds act on central nervous 
system targets by increasing the synaptic availability of monoamine neurotransmitters 
(noradrenaline, dopamine, and serotonin), both by catalysing the release of pre-synaptically 
stored neurotransmitters into the synaptic cleft, and indirectly preventing their reuptake [8, 9]. 
ATS are known by a variety of street names, including speed, whiz, uppers, goey, dexies, 
base, meth, ice, and glass. It comes in several forms including powder, paste, tablets, liquid, 
or crystals, and can be administered (dependant on form) orally, intranasally, anally, or via 
injection [7].  
 
The acute response to ATS use closely mirrors that of the adrenalin-mediated fight-or-flight 
response, characterised by a rapid increase in heart rate and blood pressure, and decrease in 
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appetite. Users report experiencing increased focus and mental alertness, an elimination of 
fatigue, an increased sense of euphoria, general elevation of mood, increased libido, and an 
improved sense of wellbeing [10]. However, adverse effects include restlessness, irritability, 
anxiety, teeth grinding, and confusion. Short-term effects of abuse include sleep disorders 
and psychosis, paranoid hallucinations, and severe mood disorders. Long-term dependence 
results in decreased neurocognitive functioning, psychiatric disorders including anxiety and 
depression, fatigue, cardiovascular problems, and an increased tendency for violent behaviour 
[11]. These problems may contribute to poorer treatment outcomes in ATS users; however 
the impacts of the upward trend in use of ATS in the adolescent treatment community on 
short- and longer-term outcomes have yet to be explored. 
Aims and Research Questions 
 
The broad aim of this report is to examine whether there are any differences in program 
success and outcomes after PALM for adolescents who endorse current ATS use compared to 
non-ATS users. Specifically, the report addresses the following research questions: 
1) Are there differences in program success for individuals who endorse current use of 
ATS at intake to PALM, compared to non-ATS users?  
2) Are there differences in self-reported outcomes (i.e., severity of dependence, 
psychological wellbeing, and recidivism) three months after involvement with PALM 
for individuals who endorsed using ATS at intake to PALM when compared to non-
ATS users? and 
3) Are there improved self-reported outcomes three months after PALM for those who 
made significant achievement in PALM compared to those who did not?  
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Study Design 
This report provides a cross-sectional descriptive evaluation of TNF’s residential treatment 
program PALM. The data utilised are routinely-collected program intake assessments, and 
follow-up assessments conducted three months after discharge from PALM. All data were 
obtained via a semi-structured self-report interview, and provided by TNF in a de-identified 
format.   
Methods 
Case Selection 
Data were made available by TNF for 2985 admissions into PALM across several NSW and 
ACT locations that took place between January 2001 and December 2015. Of these 
admissions, 556 were repeat admissions for clients into the program. Repeated entries 
introduce a problem for most types of regression analyses where the assumption is that each 
observation is independent. Given that the research questions focus on the impact of ATS use 
on treatment outcomes, rather than factors contributing to readmissions, only the initial 
appearance
1
 of each client in the dataset (determined by the earliest date of admission) was 
included in this analysis, leaving a total of 2429 unique client admissions.  
 
Missing data precluded the use of a further 314 client admissions. These observations were 
either: missing the primary outcome variable for the initial analysis (i.e., level of program 
achievement) despite being discharged from the program; were still enrolled and yet to 
complete the program at the time the data were collated and distributed (January 2016); or 
had only basic demographic information recorded without responses to symptom and drug 
                                               
1 It should be noted that, for some clients, the initial appearance in the dataset may not be their first admission 
into PALM if their previous admissions took place prior to 2001. Unfortunately, no variable was available to 
reliably determine if this was the case. Regardless, each individual client was only represented in the dataset 
once. 
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and alcohol usage questionnaires. Due to the volume of missing information within these 
cases, or the absence of a primary outcome variable, imputation of the missing information 
was deemed to be inappropriate, so these observations were excluded. Thus, the resulting 
final dataset comprised of 2115 clients with sufficient intake data for analysis.  
Outcome and Predictor Variables 
Program Success 
Although duration of stay in PALM provides an obvious and continuous measure of program 
retention, the clinical relevance of this variable to evaluate program success is questionable. 
That is, some clients may stay within the program for a prolonged period of time but make no 
substantial progress towards individually-tailored goals (negotiated at intake between staff 
and clients, dependant on the needs of the individual); whereas others may make more 
substantial progress but in a shorter timeframe. Notably, clients engaged with PALM are able 
to self-discharge irrespective of program completion, or may be asked to leave due to 
disciplinary reasons prior to completion; in these cases, the length of stay may be reduced, 
but does not preclude significant progress from being made. Thus, the level of achievement at 
discharge as determined by clinical staff (as an ordered categorical variable: no achievement; 
moderate achievement; significant achievement) was utilised as the primary outcome variable 
for program success, irrespective of the reason for discharge or length of stay. Note however, 
that supplementary analysis (see Appendix A) suggests a strong linear relationship between 
number of days spent in the program and level of achievement.  
Predictor and Outcome Variables 
The Brief Treatment Outcome Measure (BTOM) is a brief multidimensional instrument 
combining scales developed or adapted from other instruments designed to be administered at 
commencement of treatment and then at three-monthly intervals in order to monitor treatment 
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outcomes [12]. The BTOM has been found to have good reliability, acceptable validity, and 
is capable of measuring change in outcomes after treatment. Domains covered by the measure 
which have been utilised in this report include severity of dependence, psychological 
functioning, and social functioning. 
Severity of Dependence. The Severity of Dependence Scale (SDS) provides a measure of the 
psychological elements of dependence, as assessed by a 5-item scale [13] which can be 
reliably used for a variety of drug classes. In PALM, SDS is explored for the drug causing the 
greatest concern for the client. The SDS has a maximum value of 15, with higher scores 
indicating greater dependence.  
Psychological Functioning.  The Psychological Functioning Scale (PFS) is derived from the 
number of positive responses to eight yes / no questions (adapted from psychological 
wellbeing indices in the Global Appraisal of Individual Needs; [14]). These questions assess 
if the client has experienced significant problems (i.e., problems lasting for a duration of at 
least two weeks within the past three months, which causes functional impairment) across 
several psychological health domains, such as depression and anxiety. The possible values on 
the PFS range between 0 and 8, with a higher score indicating poorer functioning.  
Social Functioning. The Social Functioning Scale (SFS) assesses conflict or difficulties 
within the client’s interpersonal and professional relationships. The scale comprises the sum 
of six items (scaled in the case of not applicable responses) adapted from the 15-item social 
functioning scale of the Opiate Treatment Index [15]. The SFS has a maximum value of 18, 
with higher values reflecting poorer social functioning.  
Brief Symptom Index. The Brief Symptom Index (BSI) [16] provides a validated and reliable 
measure of psychological symptom patterns across nine primary dimensions: somatisation; 
obsessive-compulsiveness; interpersonal sensitivity; depression; anxiety; hostility; phobic 
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anxiety; paranoid ideation; and psychoticism. A global index of distress experienced across 
these domains, the positive symptom distress index (PSDI), can also be derived. The PSDI 
ranges in value between 0 and 3, with higher values indicating greater symptom distress.   
Number of Arrests. Clients were asked to self-report the number of times they had been 
arrested in the previous three months, at both intake and at three months post-PALM. It is 
acknowledged that this measure may underestimate the extent of criminal behaviour engaged 
in; however given the documented links between crime and drug use (either to fund drug use, 
or as a consequence of intoxication), it serves as a convenient proxy. Reducing criminal 
behaviour is also a desirable treatment outcome.  
Demographic Variables. In addition to self-reported psychological and physical health 
symptoms, demographic variables including age (in years) at intake, sex (male or female), 
court involvement in program referral (yes or no), DGC and current use of ATS, and the 
client’s belief that their current drug use is problematic (yes or no), were also obtained.  
Statistical analyses 
All statistical analyses were conducted in Stata 13.1, and evaluated at an alpha level of 5%. 
For effect estimates, 95% confidence intervals are also provided. Descriptive statistics 
(means and standard deviations) were calculated for the sample (stratified by ATS use) at 
intake. Pairwise correlations between continuous measures at intake are also reported. 
Ordinal logistic regression was used to model program achievement, due to the outcome 
being a three-level categorical variable with underlying order (i.e., no achievement < 
moderate achievement < significant achievement). The Brant test of parallel regression was 
used to assess the assumption of proportional odds.   
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Three month follow-up data were only available for approximately 32% of the sample 
included in the analysis of program achievement, raising some concern as to the possibility of 
bias in the follow-up sample. The reason for loss to follow-up was not provided. As such, 
descriptive statistics were calculated, and independent samples t-tests and chi-square statistics 
used to compare those for whom only intake data were available with the sample included in 
the follow-up analysis to quantify the possible sample bias.  
A set of preliminary paired-sample t-tests and Pearson pairwise correlations were conducted 
to examine changes in SDS, PFS, PSDI, and number of arrests after leaving the program and 
to explore the association between intake and follow-up measures, respectively. A series of 
multivariate linear regression models were then constructed for the continuous outcome 
variables SDS, PFS, and PSDI at follow-up (controlling for their respective values at intake), 
and including age, sex, program achievement, and ATS use as predictors. Model assumptions 
were assessed (e.g., outlying and influential observations, uncorrelated errors across 
observations) and diagnostics of model fit (e.g., normality of residuals, multicollinearity of 
predictors, linearity between predictors and outcome) were performed on the resulting final 
models. Finally, as number of arrests is in the form of count data, negative binomial 
regression modelling was utilised (as the assumption for Poisson regression that the data not 
be over-dispersed was violated, i.e., the mean count did not equal the variance) to explore 
changes in number of arrests after taking part in PALM. 
Results 
Demographics and clinical characteristics at intake 
The characteristics of the 2115 individuals included in the initial sample for analysis, 
stratified by use of ATS, are summarised in Table 1. The average client age was 16.6 years 
(SD = 1.04 years; range: 13.3 to 19.0). A large proportion of the sample (72.2%) was male. 
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Over the 15-year period covered by the dataset, cannabis was the most frequently reported 
DGC endorsed by 1033 clients (48.8%), followed by ATS (n = 475; 22.5%) and alcohol (n = 
367; 17.4%). An additional 237 clients endorsed current use of ATS at intake, who were 
collapsed with individuals endorsing ATS as their DGC to from the ATS user group (n = 712, 
33.7% of sample). Over 67% of the sample reported having been arrested at least once in the 
3 months prior to entering PALM. The average length of stay in PALM was 44 days (SD = 
32.4 days; median = 33 days; range: 1 to 142). Approximately 70% of the sample made at 
least some progress towards individually-tailored treatment goals.   
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Table 1. Sample characteristics of the 2115 clients at intake into PALM, and program 
departure statistics. Values are presented as means (standard deviations) or frequencies 
(column percentages).  
Variable 
Non-ATS users 
(n = 1403) 
ATS users 
(n = 712) 
Intake characteristics   
Age (years) 16.6 (1.1) 16.7 (1.0) 
Sex   
Male 1061 (75.6%) 465 (65.3%) 
Female 342 (24.4%) 247 (34.7%) 
Drug of greatest concern   
Opioids 109 (7.8%) 12 (1.7%) 
Cannabis 874 (62.3%) 159 (22.3%) 
Alcohol 326 (23.2%) 41 (5.8%) 
Amphetamine-type stimulants 0 (0%) 475 (66.7%) 
Other * 94 (6.7%) 25 (3.5%) 
Believe their drug use is a problem 1327 (94.6%) 668 (93.8%) 
Court involvement   
Yes 532 (37.9%) 405 (56.9%) 
No 871 (62.1%) 307 (43.1%) 
Severity of Dependence 8.8 (3.1) 9.2 (3.0) 
Psychological Functioning 4.7 (2.4) 5.3 (2.3) 
Social Functioning 8.3 (3.6) 9.1 (3.9) 
Positive Symptom Distress Index 2.0 (0.7) 2.1 (0.7) 
Number of arrests in past 3 months   
0 480 (34.2%) 203 (28.5%) 
1 - 2 622 (44.3%) 351 (49.3%) 
3 + 301 (21.5%) 158 (22.2%) 
Program departure statistics   
Days spent in program 46.7 (32.4) 38.1 (31.9) 
Achievement on Program Departure   
No Achievement 383 (27.3%) 260 (36.5%) 
Moderate Achievement 527 (37.6%) 247 (34.7%) 
Significant Achievement 493 (35.1%) 205 (28.8%) 
Reason for Program Departure   
Program Completion 412 (29.4%) 161 (22.6%) 
Self-Discharge 487 (34.7%) 315 (44.2%) 
Disciplinary Discharge 504 (35.9%) 236 (33.2%) 
*including cocaine, tranquilisers, inhalants, hallucinogens, ecstasy, and not specified.  
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Variable correlations at intake 
Table 2 displays the pairwise correlations between continuous variables at intake. Due to 
large sample size, even small correlation coefficients (r ≈ 0.10) are statistically significant at 
the p < 0.01 level. Age did not appear to be strongly associated with any of the BTOM 
subscales, nor with the PSDI. A greater severity of dependence was associated with poorer 
psychological health (indexed by both the PFS and PSDI) and poorer social functioning. As 
the PSDI and PFS measure similar underlying constructs, a moderately strong positive 
association between the measures was identified.  
 
Table 2. Pearson pairwise correlation coefficients (r) between continuous variables at intake 
(N = 2115).  
Variables SDS PFS SFS PSDI 
Age 0.11 0.04 0.04 0.00 
SDS  0.25 0.19 0.20 
PFS   0.32 0.44 
SFS    0.32 
SDS = Severity of dependence scale; PFS = Psychological functioning scale; SFS = Social 
functioning scale; PSDI = Positive symptom distress index.  
 
Achievement at departure from PALM 
An ordinal logistic regression model exploring level of achievement on program departure 
(no achievement, moderate achievement, or significant achievement) was constructed, which 
included ATS use, the demographic variables age and sex, along with SDS, PSDI, and the 
client’s belief that their drug-taking was currently a problem at intake as predictors. The 
likelihood ratio chi-square statistic [𝜒2(6) = 47.60, p < 0.001] indicated a significantly better 
fit for this model compared to a null model with no predictors. The inclusion of SFS and PFS 
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variables, or whether there was court involvement in client referral, failed to substantially 
improve the model fit, and as such were not included as predictors. The assumption of 
proportional odds was satisfactorily met [Brant test: 𝜒2(6) = 6.06, p = 0.416]. The odds ratios 
obtained from the final model are displayed in Table 3. 
Table 3. Odds ratios (and 95% confidence intervals) from ordinal logistic regression for 
achievement upon program departure for N = 2115 clients.  
Predictor Odds Ratio 95% CI Wald p-value 
ATS Use ATS user 0.69 [0.58, 0.82] <0.001 
 Non-ATS user 1.00   
Age /year 1.16 [1.07, 1.25] <0.001 
PSDI /1 unit increase 0.86 [0.76, 0.97] 0.014 
Belief that drug use is problematic    
 No 0.65 [0.46, 0.93] 0.017 
 Yes 1.00   
SDS /1 unit increase 0.97 [0.94, 0.99] 0.020 
Sex Female 1.18 [0.98, 1.41] 0.085 
 Male 1.00   
ATS = amphetamine-type stimulant; SDS = Severity of dependence scale; PSDI = Positive 
symptom distress index. 
 
The use of ATS significantly reduced the odds of making greater achievement in PALM by 
31.1% compared to clients that were not using ATS at program intake. Similarly, the odds of 
greater achievement were significantly reduced by 34.6% for clients who did not believe their 
drug use to be problematic. Greater dependence and higher psychological symptom distress 
were also associated with significantly lowered odds of achievement in the program; a one 
unit increase in SDS and PSDI was associated with 3.1% and 14.4% reduction in the odds of 
greater achievement, respectively. Each additional year of age was associated with a 
significant increase of 15.7% in the odds of greater achievement. Although female clients had 
17.5% greater odds of higher program achievement than males, this was not a statistically 
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significant difference. The predicted probabilities of each achievement category for a 
“typical” client are presented in Table 4. Clients that endorsed use of ATS had a much greater 
probability of not making any achievement in PALM than of making moderate or significant 
achievement, when all other factors are held constant.   
Table 4. Predicted probability (and 95% confidence intervals) of achievement categories for 
male clients who acknowledged that their drug taking is problematic, at mean values
^
 for age, 
SDS and PSDI.  
Achievement Category Non-ATS user ATS user 
No Achievement 0.37 [0.29-0.45] 0.46 [0.37-0.55] 
Moderate Achievement 0.37 [0.34-0.39] 0.34 [0.30-0.38] 
Significant Achievement 0.26 [0.19-0.33] 0.20 [0.14-0.25] 
^
Predicted probabilities are calculated at the following variable levels: Age = 16.62; Severity 
of Dependence Scale (SDS) = 8.95; Positive Symptom Distress Index (PSDI) = 2.03.  
 
Follow-up sample characteristics 
A large proportion of the sample (70%) included in the initial analysis of program 
achievement did not have three month follow-up data available. Table 5 provides a 
description and comparison of those who were only available at intake, with those for whom 
follow-up data (i.e., on at least one outcome measure) was also available. Overall, the follow-
up sample comprised of slightly more female clients, and had fewer clients endorsing ATS as 
their DGC, and more endorsing alcohol as their DGC, compared to the intake only sample. 
Clients that were followed-up spent significantly longer in the program, were more likely to 
have made significant achievement in the program, and had more departures due to 
completion rather than self- or disciplinary discharge compared to the intake only sample. 
There were no significant differences between the two sub-samples on intake values of the 
SDS or PSDI; yet those who were included in the follow-up sample reported poorer 
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psychological (PFS) and social functioning (SFS) than the intake only sample. The follow-up 
sample also appeared to have fewer arrests in the three month period prior to PALM. Given 
the low rate of clients in the “no achievement” category on program discharge within the 
follow-up sample, the no achievement and moderate achievement categories were collapsed 
for subsequent analyses. Of the 620 clients at follow-up, 474 had data on all four outcome 
measures, 118 had responses recorded for three outcome variables, 23 had provided 
responses for two outcome variables, and the remaining 5 clients had responses recorded for 
only one outcome variable. 
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Table 5. Intake characteristics (and program departure statistics) of the sample available only 
at intake (n = 1495), compared with those for whom both completion and follow-up data 
were available (n = 620). Values are presented as means (standard deviations) or frequencies 
(column percentages). 
Variable 
Intake  
Only 
(n = 1495) 
Follow-up 
Sample 
(n = 620) 
𝝌2 / t-test 
p value 
Intake characteristics    
Age (years) 16.6 (1.1) 16.7 (1.0) 0.012 
Sex    
Male 1104 (73.9%) 422 (68.1%)  
Female 391 (26.1%) 198 (31.9%) 0.007 
Drug of greatest concern at intake    
Opioids 89 (6.0%) 32 (5.2%)  
Cannabis 728 (48.7%) 305 (49.2%)  
Alcohol 229 (15.3%) 138 (22.3%)  
Amphetamine-type stimulants 363 (24.3%) 112 (18.1%)  
Other * 86 (5.7%) 33 (5.3%) < 0.001 
Believe their drug use is a problem 1405 (94.0%) 590 (95.2%) 0.285 
Severity of Dependence 8.9 (3.1) 9.0 (3.0) 0.771 
Psychological Functioning 4.9 (2.4) 5.2 (2.3) 0.003 
Social Functioning 8.4 (3.7) 8.9 (3.7) 0.023 
Positive Symptom Distress Index 2.0 (0.7) 2.1 (0.7) 0.368 
Number of arrests in past 3 months    
0 454 (30.4%) 229 (37.0%)  
1 - 2 702 (47.0%) 271 (43.7%)  
3 + 339 (22.7%) 120 (19.3%) 0.011 
Program departure statistics    
Days spent in program 32.9 (29.0) 70.2 (23.9) <0.001 
Achievement on Program Departure    
No Achievement 607 (40.6%) 36 (5.8%)  
Moderate Achievement 581 (38.9%) 193 (31.1%)  
Significant Achievement 307 (20.5%) 391 (63.1%) <0.001 
Reason for Program Departure    
Program Completion 237 (15.9%) 336 (54.2%)  
Self-Discharge 667 (44.6%) 135 (21.8%)  
Disciplinary Discharge 591 (39.5%) 149 (24.0%) <0.001 
*including cocaine, tranquilisers, inhalants, hallucinogens, ecstasy, and not specified.  
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Three-month outcomes after PALM 
Preliminary paired samples t-tests showed significant improvements across all four outcome 
measures of interest (SDS, PFS, PSDI, and number of arrests) three-months after departing 
PALM (Table 6). Intake values on these variables were moderately correlated with the 
follow-up values, indicating their suitability for inclusion as covariates in the regression 
models of outcomes.      
Table 6. Paired samples t-test statistics comparing outcome variables at intake to follow-up. 
Pearson pairwise correlation coefficients are also been provided.  
Variable n 
Intake 
M (SD) 
Follow-up 
M (SD) 
Correlation 
coefficient (r) 
t-test statistic 
SDS 548 8.91 (2.98) 4.56 (3.78) 0.21 t = 23.75, p < 0.001 
PFS 608 5.19 (2.30) 2.83 (2.43) 0.28 t = 20.44, p < 0.001 
PSDI 547 2.05 (0.65) 0.69 (0.70) 0.29 t = 39.29, p < 0.001 
Arrests 598 1.55 (2.32) 0.49 (1.24) 0.22 t = 10.82, p < 0.001 
SDS = Severity of dependence scale; PFS = Psychological functioning scale; PSDI = Positive 
symptom distress index. 
 
For the analyses of three-month outcomes that follow, the demographic variables age and 
sex, use of ATS at intake into PALM, whether significant achievement was made at departure 
from PALM (i.e., significant achievement vs. not significant achievement), as well as intake 
values of the relevant follow-up measure were included as covariates. An examination of 
regression diagnostics for linear models is provided in Appendix B.  
 
Severity of Dependence 
The regression coefficients for the model of SDS at follow-up are displayed in Table 7. The 
overall model was statistically significant [F(5,542) = 10.09, p < 0.001, R
2
 = 0.085], 
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providing strong evidence to reject the null hypothesis that all coefficients in the model are 
equal to 0. After controlling for SDS at intake, individuals who endorsed ATS use at intake 
into PALM did not significantly differ in their severity of dependence from those who were 
not using ATS. However, clients that made significant achievement in PALM reported 
significantly lower SDS at follow-up by 1.24 [95% CI: 0.61, 1.87] compared to those who 
did not make significant achievement (when all other factors are held constant). For each 
one-year increase in age, SDS was significantly reduced by 0.39 [95% CI: 0.07, 0.71]. Sex of 
the client did not make a significant independent contribution to the model. Linear 
predictions of SDS at follow- are illustrated in Figure 1. 
Table 7. Regression coefficients for model of severity of dependence at follow-up (n = 548).   
Variable ?̂? 
SE 
(?̂?) 
95% CI 
(?̂?) 
p-value 
Std  
?̂? 
ATS use at intake -0.64 0.35 [-1.31, 0.04] 0.066 -0.077 
Significant program achievement -1.24 0.32 [-1.87, -0.61] <0.001 -0.159 
Age -0.39 0.16 [-0.71, -0.07] 0.017 -0.010 
Sex (Female) 0.18 0.34 [-0.49, 0.85] 0.597 0.022 
SDS at intake 0.28 0.05 [0.17, 0.38] <0.001 0.218 
ATS = amphetamine-type stimulant; SDS = Severity of dependence scale 
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Figure 1. Marginal linear predictions of SDS at follow-up, as a function of ATS use, program 
achievement, and client sex. Predictions are plotted at sample mean values of age (16.7 years) 
and SDS at intake (8.91). Error bars indicate 95% confidence intervals.  
 
Psychological Functioning 
Table 8 provides the coefficients for the statistically significant regression model [F(5,602) = 
19.72, p < 0.001, R
2
 = 0.141] of PFS at follow-up. Clients who reported the use of ATS at 
intake to PALM did not significantly differ in PSF at follow-up from those who did not 
endorse ATS use (after controlling for intake values of PSF). Commensurate with the SDS, 
clients who made significant program achievement had significantly lower PFS (reflecting 
better psychological functioning and wellbeing) at follow-up [0.42, 95% CI: 0.05, 0.79, p = 
0.028] than those who did not make significant program achievement.  Older clients also 
reported significantly better psychological functioning at follow-up, with each additional year 
of age reducing the PFS by 0.19 [95% CI: 0.00, 0.38, p = 0.047]. Female clients had 
significantly poorer psychological functioning at follow-up, with PFS values greater than 
male clients by 1.17 [95% CI: 0.75, 1.59] (when all other factors are held constant). Figure 2 
provides the marginal linear predictions of PFS at follow-up.  
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Table 8. Regression coefficients for model of psychological functioning at follow-up (n = 
608).   
Variable ?̂? 
SE 
(?̂?) 
95% CI 
(?̂?) 
p-value 
Std  
?̂? 
ATS use at intake 0.11 0.21 [-0.29, 0.51] 0.595 0.020 
Significant program achievement -0.42 0.19 [-0.79, -0.05] 0.028 -0.083 
Age -0.19 0.10 [-0.38, 0.00] 0.047 -0.076 
Sex (Female) 1.17 0.22 [0.75, 1.59] <0.001 0.225 
PFS at intake 0.21 0.04 [0.13, 0.29] <0.001 0.199 
ATS = amphetamine-type stimulant; PFS = Psychological functioning scale 
 
 
Figure 2. Marginal linear predictions of PFS at follow-up, as a function of ATS use, program 
achievement, and client sex. Predictions are plotted at sample mean values of age (16.7 years) 
and PFS at intake (5.19). Error bars indicate 95% confidence intervals. 
 
Positive Symptom Distress Index 
A significant regression model for PSDI at follow-up was generated [F(5,541) = 13.06, p < 
0.001, R
2
 = 0.108], the coefficients of which are displayed in Table 9.  After controlling for 
intake PSDI values, there was no significant difference in PSDI at follow-up between those 
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who endorsed the use of ATS at intake, and those who did not. Significant program 
achievement was associated with significantly reduced PSDI at follow up, with a difference 
of 0.16 [95% CI: 0.05, 0.28] compared to clients who did not make significant achievement. 
Age did not make a significant unique contribution to the model. As with psychological 
functioning, PSDI at follow up was greater by 0.17 [95% CI: 0.04, 0.30] for females than 
males. Figure 3 displays the linear marginal predictions for PSDI at follow-up. 
Table 9. Regression coefficients for model of positive symptom distress at follow-up (n = 
547).   
Variable ?̂? 
SE 
(?̂?) 
95% CI 
(?̂?) 
p-value 
Std  
?̂? 
ATS use at intake -0.06 0.06 [-0.19, 0.06] 0.343 -0.039 
Significant program achievement -0.16 0.06 [-0.28, -0.05] 0.006 -0.112 
Age 0.01 0.03 [-0.05, 0.07] 0.729 0.014 
Sex (Female) 0.17 0.07 [0.04, 0.30] 0.013 0.110 
PSDI at intake 0.27 0.05 [0.18, 0.36] <0.001 0.253 
ATS = amphetamine-type stimulant; PSDI = Positive Symptom Distress Index 
 
Figure 3. Marginal linear predictions of PSDI at follow-up, as a function of ATS use, 
program achievement, and client sex. Predictions are plotted at sample mean values of age 
(16.7 years) and PSDI at intake (2.05). Error bars indicate 95% confidence intervals. 
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Number of Arrests 
Number of arrests in the three-months following discharge from PALM was modelled using 
negative binomial regression. The final model was significantly different from a model with 
no predictors [𝜒2(5) = 52.13, p < 0.001]. The model coefficients are displayed in Table 10; 
note that coefficients derived from negative binomial regression are additive on the log 
number of arrests. After controlling for the number of arrests prior to entering PALM, clients 
endorsing ATS use at intake did not significantly differ in the expected number of arrests 
from those who were not using ATS. Significant program achievement was associated with a 
0.64 reduction in the log expected number of arrests [95% CI: 0.30, 0.98] compared to clients 
who did not make significant program achievement. Older age was associated with 
significantly fewer arrests, with each additional year of age reducing the log expected number 
of arrests by 0.19 [95% CI: 0.02, 0.36, p = 0.026]. The log expected number of arrests was 
also significantly lower for females than males by 0.13 [95% CI: 0.06, 0.19]. The predicted 
number of arrests in the three months preceding follow-up is displayed in Figure 4.  
Table 10. Negative binomial regression coefficients and incidence-rate ratios for number of 
arrests in previous three months reported at follow-up (n = 598).   
Variable ?̂? 
SE 
(?̂?) 
95% CI 
(?̂?) 
p-value IRR 
ATS use at intake 0.36 0.20 [-0.02, 0.75] 0.063 1.44 
Significant program achievement -0.64 0.17 [-0.98, -0.30] <0.001 0.53 
Age -0.19 0.08 [-0.36, -0.02] 0.026 0.83 
Sex (Female) -0.83 0.21 [-1.24, -0.42] <0.001 0.44 
Arrests in 3 months pre-intake 0.13 0.03 [0.06, 0.19] <0.001 1.13 
ATS = amphetamine-type stimulant 
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Figure 4. Predicted number of arrests at follow-up, presented as a function of ATS use, 
program achievement, and client sex. Predictions are plotted at mean sample values of age 
(16.7 years) and number of arrests prior to intake (1.55). Error bars indicate 95% confidence 
intervals. 
 
Summary of Findings 
This report explored the impact of ATS use on achievement in an adolescent residential 
treatment program (TNF’s PALM), and outcomes three months after program departure. 
After controlling for clients’ age, severity of drug dependence, and psychological health 
indices, clients who self-reported the use of ATS at intake to PALM were less likely to make 
‘significant achievement’ in their individualised treatment goals than non-ATS users. There 
was a large loss-to-follow up in the sample at three months, reflecting a possible bias towards 
greater program achievement in the remaining sample. There appeared to be no differences in 
any of the self-reported outcomes (severity of dependence, psychological functioning, 
positive symptom distress, and number of arrests) three months after program departure 
between ATS and non-ATS users after controlling for demographic and intake values of the 
respective measures. However, improved outcomes across all four outcome measures were 
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observed for individuals who made significant achievement in PALM compared to those who 
did not, irrespective of their use of ATS at intake to the program. 
Limitations and Recommendations 
The analyses reported here are somewhat limited by the large volume of missing data. This is 
an inherent problem with multi-site administrative data collections performed by multiple 
individuals relying on client self-report, particularly when the primary purpose of data 
collection is not necessarily research. This limitation is further acknowledged for the three-
month follow-up data, where only 30% of the sample had data available (leading to a possible 
sample bias) without information as to why follow-up data had not been ascertained; 
individuals may have re-entered the PALM program or an alternative residential treatment 
program within the 90-day period, or three months may not have elapsed at the time of the 
database being extracted. Alternatively, individuals may have been incarcerated, hospitalised, 
passed away, or simply may not have updated their contact details or chose not to respond. 
Many of these potential reasons for an absence of follow-up data, such as health or legal 
issues, could serve as objective outcome indices; which in most cases could be ascertained 
through data linkage with routine data collections (e.g., Mental Health Ambulatory, Admitted 
Patient, and Emergency Department Data Collections).   
A further limitation of these analyses is the reliance on subjective and self-reported measures 
as outcomes. The primary outcome measure of achievement in the program is based on 
subjective clinical judgement, rather than reflecting a tangible and objective value. Of course, 
this limitation is almost unavoidable given the individually-tailored nature of the program, 
whereby the specific needs of the client, as well as goals that they wish to achieve, are 
incorporated into the treatment plan and will differ markedly across clients. Similarly, the 
majority of variables also involve self-report, often relying on retrospective memory of 
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events, such as drug usage behaviour, over a previous period of time. These types of 
measures may succumb to recall bias whereby the client may have difficulties accurately 
remembering events, experiences, or feelings that happened in the past. Response biases (e.g., 
social desirability bias) may also occur, whereby individuals respond in an untrue or 
misleading way in order to make their behaviours seem more (or less) socially acceptable. As 
suggested above, the use of objective measures that can be operationally defined in a 
consistent manner across program participants would assist in limiting these biases.  
A descriptive modelling approach (rather than an explanatory or predictive approach [17]) 
was employed in this report to ascertain the associations between specific dependant and 
independent variables. As such, minor violations in regression model assumptions were 
tolerated (see Appendix B), and variables that did not make a significant unique contribution 
were retained in the final models. Further refinement to the models could be performed by 
removal of non-contributing variables, applying transformations to continuous predictor 
variables, or including higher-order (e.g., quadratic) or interaction terms. Although these 
strategies may explain a greater proportion of the variance and strengthen the predictive 
ability of the model, they introduce additional complexity in the interpretation of resulting 
parameters; thus simpler models were deemed sufficient in this context to answer the 
specified research questions.  
 
  
Erin Cvejic   Page | 36 
References 
[1] Coffey C, Veit F, Wolfe R, Cini E, Patton GC. Mortality in young offenders: 
retrospective cohort study. BMJ 2003;326(7398):1064. 
doi:10.1136/bmj.326.7398.1064. 
[2] Kosky RJ, Sawyer MG, Gowland JC. Adolescents in custody: hidden psychological 
morbidity? Med J Aust 1990;153(1):24-7. 
[3] Fazel S, Doll H, Långström N. Mental Disorders Among Adolescents in Juvenile 
Detention and Correctional Facilities: A Systematic Review and Metaregression 
Analysis of 25 Surveys. J Am Acad Child Adolesc Psychiatry 2008;47(9):1010-9. 
doi:10.1097/CHI.ObO13e31817eecf3. 
[4] van der Put CE, Stams GJJM, Hoeve M, Deković M, Spanjaard HJM, van der Laan 
PH, et al. Changes in the Relative Importance of Dynamic Risk Factors for 
Recidivism During Adolescence. International Journal of Offender Therapy and 
Comparative Criminology 2012;56(2):296-316. doi:10.1177/0306624x11398462. 
[5] Australian Institute of Health and Welfare. National Drug Strategy Household Survey 
detailed report 2013. (AIHW Cat. No. PHE 183; Drug Statistics Series No.28) 
Canberra: AIHW, 2014. http://www.aihw.gov.au/alcohol-and-other-drugs/ndshs-
2013. 
[6] Nathan S, Bethmont A, Rawstorne PR, Ferry M, Hayen A. Trends in drug use among 
adolescents admitted to residential treatment in Australia. Med J Aust 
2016;204(4):149-50. doi:10.5694/mja15.01018. 
[7] National Drug Research Institute, Australian Institute of Criminology. National 
Amphetamine-Type Stimulant Strategy Background Paper. (Monograph Series No. 
69) Canberra: Australian Government Department of Health and Ageing, 2007. 
http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/
98CFCAEC1A10BE00CA2574C5000C2641/$File/mono69.pdf. 
[8] Cruickshank CC, Dyer KR. A review of the clinical pharmacology of 
methamphetamine. Addiction 2009;104(7):1085-99. doi:10.1111/j.1360-
0443.2009.02564.x. 
[9] Rothman RB, Baumann MH. Monoamine transporters and psychostimulant drugs. 
Eur J Pharmacol 2003;479(1–3):23-40. doi:10.1016/j.ejphar.2003.08.054. 
Erin Cvejic   Page | 37 
[10] Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of 
methamphetamine use. Drug and Alcohol Review 2008;27:253-62. 
doi:10.1080/09595230801923702. 
[11] Homer BD, Solomon TM, Moeller RW, Mascia A, DeRaleau L, Halkitis PN. 
Methamphetamine abuse and impairment of social functioning: A review of the 
underlying neurophysiological causes and Behavioral implications. Psychol Bull 
2008;134(2):301-10. doi:10.1037/0033-2909.134.2.301. 
[12] Lawrinson P, Copeland J, Indig D. The Brief Treatment Outcome Measure: Opioid 
maintenance pharmacotherapy (BTOM) Manual. (Technical Report #156) Sydney, 
Australia: National Drug and Alcohol Research Centre, University of New South 
Wales, 2003. 
[13] Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The Severity of 
Dependence Scale (SDS): psychometric properties of the SDS in English and 
Australian samples of heroin, cocaine and amphetamine users. Addiction 
1995;90(5):607-14. doi:10.1046/j.1360-0443.1995.9056072.x. 
[14] Dennis ML, Rouke KM, Caddell JM. Global Appraisal of Individual Needs: 
Administration Manual. NC: Research Triangle Institute, 1993. 
[15] Darke S, Hall W, Wodaki A, Heather N, Ward J. Development and validation of a 
multidimensional instrument for assessing outcome of treatment among opiate users: 
the Opiate Treatment Index. Br J Addict 1992;87(5):733-42. doi:10.1111/j.1360-
0443.1992.tb02719.x. 
[16] Derogatis LR. Brief Symptom Inventory (BSI). Administration, Scoring, and 
Procedures Manual. 3rd Edition. MN: National Computer Systems, Inc, 1993. 
[17] Shmueli G. To explain or to predict? Statistical Science 2010;25(3):289-310. 
doi:10.1214/10-STS330. 
 
 
  
Erin Cvejic   Page | 38 
Appendices 
Appendix A: Days in Program vs. Program Achievement 
An ordinal logistic regression was conducted to explore the association between number of 
days spent in PALM, and the level of achievement at discharge (no achievement, moderate 
achievement, significant achievement). The likelihood ratio statistic [𝜒2(1) = 1958.44, p < 
0.001] indicated a significantly better fit than an empty model, with the Brant test [𝜒2(1) = 
0.08, p = 0.781] of the parallel regression assumption being satisfied. For each day spent in 
PALM, the odds (unadjusted for any other possible covariates) of making greater 
achievement increase by 8.9% [95% CI: 8.3%, 9.5%, p < 0.001]. Figure A1 shows the 
predicted probability of significant achievement in PALM as a function of the number of 
days spent in PALM. As number of days in the program increases, so too does the probability 
of making significant achievement.  
 
Figure A1. Predicted probability of significant achievement in PALM as a function of 
number of days spent in program. The shaded area denotes the 95% confidence interval of the 
prediction.  
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Appendix B: Regression Model Diagnostics 
Given the restricted ranges of possible values on the variables included in the linear 
regression models, the opportunity for an observation to be an outlier (other than due to data 
entry errors) or exert undue influence on the parameter estimates are fairly limited.  
SDS at follow-up 
 
No extreme leverage values were 
observed in the sample (all 
<0.035). 
 
No excessively large DFBETA 
values (all < |0.25|) across any of 
the predictor variables. 
 
Residuals were approximately 
normally distributed. 
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The plot of residual versus fitted 
values provided evidence of 
heteroscedasticity, due to the 
lower bound value of the 
outcome being restricted to 0. 
Note, the use of truncated 
regression did not substantially 
alter the resulting coefficients, 
nor impact on the residual 
variance patterns.  
 
 
Augmented component-plus-
residual plots (ACPRPs) for the 
continuous variables age and 
intake SDS did not provide cause 
for concern about non-linearity 
between predictors and 
outcomes. 
Variable VIF 1/VIF 
ATS Use 1.04 0.963 
Sig. Achievement 1.00 0.998 
Age 1.03 0.972 
Sex (Female) 1.05 0.953 
Intake SDS 1.03 0.971 
Mean VIF 1.03  
 
Variance Inflation Factors (VIF) 
did not provide evidence of 
multicollinearity between the 
prediction variables. 
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PFS at follow-up 
 
No extreme leverage values were 
observed in the sample (all 
<0.025). 
 
No excessively large DFBETA 
values (all < |0.215|) across any 
of the predictor variables. 
 
Residuals deviated slightly away 
from a normal distribution, but 
not excessively. 
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The plot of residual versus fitted 
values provided evidence of 
heteroscedasticity due to the 
lower bound value of the 
outcome being restricted to 0.  
 
 
ACPRPs for the continuous 
variables age and PFS at intake 
suggested linearity between 
predictors and outcomes. 
Variable VIF 1/VIF 
ATS Use 1.04 0.966 
Sig. Achievement 1.00 0.999 
Age 1.02 0.982 
Sex (Female) 1.20 0.836 
Intake PFS 1.15 0.867 
Mean VIF 1.08  
 
VIFs provide no evidence of 
substantial multicollinearity 
between the prediction variables. 
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PSDI at follow-up 
 
No extreme leverage values were 
observed in the sample (all 
<0.035). 
 
No excessively large DFBETA 
values (all < |0.45|) across the 
predictor variables. 
 
Some deviation away from 
normality for the residuals was 
observed in this model. 
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The restriction of the lower 
bound of the outcome being 0 
generated evidence of 
heteroscedasticity in the plot of 
residual versus fitted values.  
 
 
 
ACPRPs for the continuous 
variables age and intake PSDI 
suggested some non-linearity 
between predictors and outcomes 
at the extreme ends of the range.  
Variable VIF 1/VIF 
ATS Use 1.04 0.962 
Sig. Achievement 1.00 0.997 
Age 1.02 0.980 
Sex (Female) 1.19 0.839 
Intake PSDI 1.17 0.854 
Mean VIF 1.09  
 
VIFs did not provide evidence of 
multicollinearity between the 
prediction variables. 
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Arrests in three months prior to follow-up 
 
 
Number of arrests in three 
months prior to PALM intake, 
and prior to follow-up are 
approximately Poisson 
distributed. 
Likelihood-ratio test of 𝛼 = 0: 𝜒2(1) = 159.99, p < 0.001 
Data provided strong evidence of 
over-dispersion, suggesting 
negative-binomial regression is 
more appropriate than a Poisson 
model. 
  
Variable VIF 1/VIF 
ATS Use 1.03 0.971 
Sig. Achievement 1.00 0.999 
Age 1.02 0.980 
Sex (Female) 1.06 0.943 
Intake Arrests 1.02 0.980 
Mean VIF 1.09  
 
No collinearity between predictor 
variables was evident from 
examination of the VIFs.  
 
 
 
